EGFR and lung adenocarcinoma: Cancer and oncology genome mapping (CGA) showed that EGFR mutations were most common in female lung adenocarcinoma patients, while mutations in RNA-binding motif protein 10 (RBM10) were most common in male lung adenocarcinoma patients.